NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 201 filers reported holding NEVRO CORP in Q1 2022. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,731,698 | -13.7% | 194,157 | +14.1% | 0.00% | – |
| Q2 2023 | $4,326,255 | -45.1% | 170,191 | -21.9% | 0.00% | -100.0% |
| Q1 2023 | $7,874,917 | -52.2% | 217,840 | -47.7% | 0.00% | -50.0% |
| Q4 2022 | $16,484,252 | +167.0% | 416,269 | +214.2% | 0.00% | +100.0% |
| Q3 2022 | $6,173,000 | -24.9% | 132,482 | -29.3% | 0.00% | 0.0% |
| Q2 2022 | $8,218,000 | -32.7% | 187,495 | +11.0% | 0.00% | 0.0% |
| Q1 2022 | $12,217,000 | +22.5% | 168,914 | +37.3% | 0.00% | 0.0% |
| Q4 2021 | $9,969,000 | -43.6% | 122,981 | -19.0% | 0.00% | -50.0% |
| Q3 2021 | $17,671,000 | -36.2% | 151,843 | -9.1% | 0.00% | -33.3% |
| Q2 2021 | $27,708,000 | -45.3% | 167,133 | -54.0% | 0.00% | -40.0% |
| Q1 2021 | $50,674,000 | +17.4% | 363,259 | +45.7% | 0.01% | -16.7% |
| Q4 2020 | $43,161,000 | +15.3% | 249,340 | -7.2% | 0.01% | +20.0% |
| Q3 2020 | $37,434,000 | +5.2% | 268,731 | -9.8% | 0.01% | -16.7% |
| Q2 2020 | $35,578,000 | +52.9% | 297,801 | +28.0% | 0.01% | +50.0% |
| Q1 2020 | $23,266,000 | +46.3% | 232,713 | +72.0% | 0.00% | +100.0% |
| Q4 2019 | $15,898,000 | +20.7% | 135,268 | -11.7% | 0.00% | 0.0% |
| Q3 2019 | $13,171,000 | +33.0% | 153,197 | +0.3% | 0.00% | +100.0% |
| Q2 2019 | $9,905,000 | +20.5% | 152,788 | +16.2% | 0.00% | 0.0% |
| Q1 2019 | $8,223,000 | -76.4% | 131,540 | -85.3% | 0.00% | -83.3% |
| Q4 2018 | $34,900,000 | +190.6% | 897,416 | +325.9% | 0.01% | +200.0% |
| Q3 2018 | $12,009,000 | -37.8% | 210,695 | -12.9% | 0.00% | -33.3% |
| Q2 2018 | $19,311,000 | -14.3% | 241,846 | -7.0% | 0.00% | -25.0% |
| Q1 2018 | $22,538,000 | -3.3% | 260,045 | -23.0% | 0.00% | 0.0% |
| Q4 2017 | $23,305,000 | -18.5% | 337,574 | +7.3% | 0.00% | 0.0% |
| Q3 2017 | $28,588,000 | +95.4% | 314,570 | +60.0% | 0.00% | +33.3% |
| Q2 2017 | $14,633,000 | +11.1% | 196,595 | +39.9% | 0.00% | 0.0% |
| Q1 2017 | $13,169,000 | +28.9% | 140,545 | -0.0% | 0.00% | +50.0% |
| Q4 2016 | $10,215,000 | -3.5% | 140,581 | +38.7% | 0.00% | 0.0% |
| Q3 2016 | $10,581,000 | +299.3% | 101,354 | +182.2% | 0.00% | +100.0% |
| Q2 2016 | $2,650,000 | +17.2% | 35,918 | -10.7% | 0.00% | – |
| Q1 2016 | $2,262,000 | +862.6% | 40,200 | +1055.5% | 0.00% | – |
| Q4 2015 | $235,000 | +3816.7% | 3,479 | +2661.1% | 0.00% | – |
| Q3 2015 | $6,000 | -94.5% | 126 | -93.8% | 0.00% | – |
| Q2 2015 | $109,000 | +10800.0% | 2,019 | +7377.8% | 0.00% | – |
| Q1 2015 | $1,000 | – | 27 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |